Factors that could hinder the growth of the GLP-1 receptor agonist market in the future include misuse, off-label use, and non-medical consumption, high drug costs compared to standard diabetes or obesity therapy and impact of trade war and tariffs
Liraglutide has demonstrated both cardiovascular benefits in addition to its excellent glucose-lowering effects
It is important to note that the upregulation of IL-33 observed in some GLP-1 studies does not universally guarantee mucosal defense, as IL-33 can also drive potent Th2 inflammatory responses depending on the tissue context (53)
The Data were analyzed using the Statistical Package for the Social Sciences version 27.0 (SPSS IBM Corp, Armonk, NY, USA)
pneumoniae , and to compare these findings with those reported for ahpD [29] and tpxD [7], we constructed deletion mutants for each gene in the R801 strain, and we determined H 2 O 2 susceptibility expressed in percentage of bacterial survival that survived at 20 mM H 2 O 2 for 30 min [7]